Stocksigma LogoStocksigma Logo

Oxygenta Pharmaceutical Reports Q2 FY27 Results with Revenue Growth and Narrowing Net Loss

Oxygenta Pharmaceutical reported revenue from operations of ₹3,349.39 lakhs for the quarter ended 30th Sep'26, up 134.18% YoY from ₹1,430.23 lakhs, though

Oxygenta Pharmaceutical Reports Q2 FY27 Results with Revenue Growth and Narrowing Net Loss

Oxygenta Pharmaceutical Ltd · Financial Result · 10 Nov 2026, 10:29 pm

Oxygenta Pharmaceutical Reports Q2 FY27 Results with Revenue Growth and Narrowing Net Loss Oxygenta Pharmaceutical reported revenue from operations of ₹3,349.39 lakhs for the quarter ended 30th Sep'26, up 134.18% YoY from ₹1,430.23 lakhs, though down 9.47% QoQ. Total expenses stood at ₹3,690.96 lakhs, leading to a loss before tax of ₹339.54 lakhs compared to a loss of ₹643.78 lakhs in Q2 FY26. Net loss narrowed YoY to ₹273.53 lakhs from ₹493.04 lakhs. Diluted EPS improved to ₹(0.74) versus ₹(1.33) YoY. For H1 FY27, revenue reached ₹7,049.09 lakhs with a net loss of ₹483.90 lakhs.

Original exchange filing (PDF)

More announcements from Oxygenta Pharmaceutical Ltd

All Oxygenta Pharmaceutical Ltd announcements